Perfil
Jens Schneider-Mergener is the founder of Pharvaris NV, which was founded in 2015.
He was the Chief Executive Officer at Shire Orphan Therapies GmbH.
He also served as the Chief Executive Officer at AdrenoMed AG from 2019 to 2021.
Dr. Schneider-Mergener received his undergraduate degree from the University of Bielefeld and his doctorate from Ludwig-Maximilians-Universität München.
Antiguos cargos conocidos de Jens Schneider-Mergener.
| Empresas | Cargo | Fin |
|---|---|---|
AdrenoMed AG
 AdrenoMed AG Pharmaceuticals: MajorHealth Technology AdrenoMed AG develops a drug to decrease mortality in severe sepsis. The company was founded by Bernd Wegener, Gerald Heinz Möller and Andreas Bergmann in 2009 and is headquartered in Berlin, Germany. | Director Ejecutivo | 01/01/2021 |
| PHARVARIS N.V. | Fundador | - |
Shire Orphan Therapies GmbH
 Shire Orphan Therapies GmbH Pharmaceuticals: MajorHealth Technology Shire Orphan Therapies GmbH engages in the development, manufacture, and distribution of chemical and biochemical products, ingredients, as well as pharmaceutical and diagnostic products. The company was founded in 1994 and is headquartered in Berlin, Germany. | Presidente | - |
Formación de Jens Schneider-Mergener.
| University of Bielefeld | Undergraduate Degree |
| Ludwig-Maximilians-Universität München | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| PHARVARIS N.V. | Health Technology |
| Empresas privadas | 2 |
|---|---|
Shire Orphan Therapies GmbH
Shire Orphan Therapies GmbH Pharmaceuticals: MajorHealth Technology Shire Orphan Therapies GmbH engages in the development, manufacture, and distribution of chemical and biochemical products, ingredients, as well as pharmaceutical and diagnostic products. The company was founded in 1994 and is headquartered in Berlin, Germany. | Health Technology |
AdrenoMed AG
AdrenoMed AG Pharmaceuticals: MajorHealth Technology AdrenoMed AG develops a drug to decrease mortality in severe sepsis. The company was founded by Bernd Wegener, Gerald Heinz Möller and Andreas Bergmann in 2009 and is headquartered in Berlin, Germany. | Health Technology |
- Bolsa de valores
- Insiders
- Jens Schneider-Mergener
